Phenotypic diversity of reversible tumorigenesis enabled by cerebral organoids

Graham MS, Codega P, Campos C, Rosenblum M, Antonescu C, Grogan MM, Nandakumar S, Coleman C, Carcamo S, Hamilton G, Hasson D, Benhamida J, Bale T, von Deimling A, Socci ND and Mellinghoff IK.

In preparation.

Liquid biopsy in the diagnosis of primary brain tumors

Bale TA, Mellinghoff IK, Graham MS.

Adv Cancer Res. 2025; 166: 81-102. doi: 10.1016/bs.acr.2025.05.004. Epub 2025 Jun 6.
PubMed Link >

The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutant

Le Rhun E, Bink A, Felsberg J, Gramatzki D, Brandner S, Benhamida JK, Wick A, Tonn JC, Mohme M, Tabatabai G, Capper D, Snuderl M, Razis E, Ronellenfitsch MW, Neidert N, Ng HK, Pohl U, Bale T, Quach S, Rieger D, Schüller U, Onken J, Drüschler K, Maurage CA, Regli L, Healy E, Graham M, Hortobagyi T, Paine S, Bridges L, Lausova T, Medici V, Sievers P, Schrimpf D, Wick W, Sahm F, Reifenberger G, von Deimling A, Weller M.

Neuro Oncol. 2025 Jul 30; 27 (6): 1519-1535. doi: 0.1093/neuonc/noaf015.
PubMed Link >

The promise of metabolic imaging in diffuse midline glioma.

Lovibond S, Gewirtz AN, Pasquini L, Krebs S, Graham MS.

Neoplasia. 2023 May 1; 39: 100896. doi: 10.1016/j.neo.2023.100896. Epub 2023 Mar 20.
PubMed Link >

Leptomeningeal disease in histone-mutant gliomas

Diaz M, Rana S, Silva Correia CE, Reiner AS, Lin AL, Miller AM, Graham MS, Chudsky S, Bale TA, Rosenblum M, Karajannis MA, Pentsova E.

Neuro Oncol Adv. 2023 May 29; 5 (1): vdad068. doi: 10.1093/noajnl/vdad068.
PubMed Link >

ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma

Blandin AF, Giglio R, Graham MS, Garcia G, Malinowski S, Woods JK, Ramkissoon S, Ramkissoon L, Dubois F, Schoolcraft K, Tsai J, Wang D, Jones R, Vogelzang J, Pelton K, Becker S, Watkinson F, Sinai C, Cohen EF, Booker MA, Tolstorukov MY, Haemels V, Goumnerova L, Wright K, Kieran M, Fehnel K, Reardon D, Tauziede-Espariat A, Lulla R, Carcamo B, Chaleff S, Charest A, De Smet F, Ligon AH, Dubuc A, Pages M, Varlet P, Wen PY, Alexander BM, Chi S, Alexandrescu S, Kittler R, Bachoo R, Bandopadhayay P, Beroukhim R, Ligon KL.

Clin Cancer Res. 2023 Jul 14; 29 (14): 2651-2667. doi: 10.1158/1078-0432.CCR-21-3521.
PubMed Link >

Meningeal lymphatics prime tumor immunity in glioblastoma

Graham MS, Mellinghoff IK.

Cancer Cell. 2021 Mar 8; 39 (3): 304-306. doi: 10.1016/j.ccell.2021.02.012.
PubMed Link >

Histone-Mutant Glioma: Molecular Mechanisms, Preclinical Models, and Implications for Therapy

Graham MS, Mellinghoff IK.

Int J Mol Sci. 2020 Sep 29; 21 (19): 7193. doi: 10.3390/ijms21197193.
PubMed Link >

BMP signaling induces astrocytic differentiation of clinically derived oligodendroglioma propagating cells

Srikanth M, Kim J, Das S, Kessler JA

Mol Cancer Res. 2014 Feb 1; 12 (2): 283-94. doi: 10.1158/1541-7786.MCR-13-0349. Epub 2013 Nov 22.
PubMed Link >

Nanofiber-mediated inhibition of focal adhesion kinase sensitizes glioma stemlike cells to epidermal growth factor receptor inhibition

Srikanth M, Das S, Berns EJ, Kim J, Stupp SI, Kessler JA.

Neuro Oncol. 2013 Mar 1; 15 (3): 319-29. doi: 10.1093/neuonc/nos316. Epub 2013 Jan 17.
PubMed Link >

Cadherin-11 regulates motility in normal cortical neural precursors and glioblastoma

Schulte JD, Srikanth M, Das S, Zhang J, Lathia JD, Yin L, Rich JN, Olson EC, Kessler JA, Chenn A.

PLoS One. 2013 Aug 8; 8 (8): e70962. doi: 10.1371/journal.pone.0070962.
PubMed Link >

Nanotechnology-novel therapeutics for CNS disorders.

Srikanth M, Kessler JA.

Nat Rev Neurol. 2012 Apr 24; 8 (6): 307-18. doi: 10.1038/nrneurol.2012.76.
PubMed Link >